NEW! First Quantitative SARS-CoV-2 Antibody ELISA Kits from Diapharma
Posted: September 30, 2020
The quality you trust from Diapharma
New! First Quantitative SARS-CoV-2 ELISAs* for detection of IgG antibodies
*For Research Use Only in the US & Canada
- Ideal for COVID-19 research, epidemiological studies, and vaccine development
TECHNOZYM anti SARS-CoV-2 NP IgG test kit (cat. no.: 5600200)
- Reacts sensitively in the early stages of the immune response
- Includes 96 test wells + calibrator and control material
- Cut- off: 5 U/mL
- Negative Agreement: 99.8%
- Positive Agreement (days post symptom onset):
- <5 d: 14.7 %
- 5-10 d: 45.7 %
- 11-15 d: 76.5 %
- > 15 d: 100%
TECHNOZYM anti SARS-CoV-2 RBD IgG test kit (cat. no.: 5600100)
- Reacts sensitively in the later stages of the immune response
- Includes 96 test wells + calibrator and control material
- Cut- off: 5 U/mL
- Negative Agreement: 99.3%
- Positive Agreement (days post symptom onset):
- <5 d: 5.9 %
- 5-10 d: 34.3 %
- 11-15 64.7 %
- >15 d: 100%
- Kits manufactured in Austria in collaboration with Florian Krammer, PhD (Icahn School of Medicine at Mount Sinai, New York)
Questions? Our scientific support staff is happy to discuss any product in our lineup.
1.800.447.3846 / techsupport@diapharma.com
Over 20 years of scientific expertise,
with support just a call or click away.
| Visit diapharma.com |
Diapharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069
ML-00-00681Rev01